Repligen (NASDAQ:RGEN – Get Rating) had its price objective dropped by research analysts at Royal Bank of Canada from $170.00 to $157.00 in a note issued to investors on Wednesday, The Fly reports. Royal Bank of Canada’s price target would suggest a potential downside of 3.20% from the stock’s previous close. A number of other […]